Targeting AT2 receptors in renal disease. 2021

Tianxin Yang
Internal Medicine, University of Utah, Salt Lake City, Utah.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D044139 Receptor, Angiotensin, Type 2 An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR. Angiotensin II Type 2 Receptor,Angiotensin Type 2 Receptor,Receptor, Angiotensin II Type 2,Angiotensin AT2 Receptor,AT2 Receptor, Angiotensin,Receptor, Angiotensin AT2

Related Publications

Tianxin Yang
November 2017, Pharmacological research,
Tianxin Yang
July 2014, Current hypertension reports,
Tianxin Yang
December 2008, Pharmacology & therapeutics,
Tianxin Yang
January 2022, Circulation research,
Tianxin Yang
March 2017, Current hypertension reports,
Tianxin Yang
January 2013, Pflugers Archiv : European journal of physiology,
Tianxin Yang
February 2006, American journal of physiology. Renal physiology,
Tianxin Yang
October 2003, Kidney international. Supplement,
Tianxin Yang
April 2008, Trends in endocrinology and metabolism: TEM,
Copied contents to your clipboard!